Efficacy and Safety of Tildrakizumab in Older Patients: Pooled Analyses of Two Randomized Phase III Clinical Trials (reSURFACE 1 and reSURFACE 2) Through 244 Weeks

Authors :: Haar, E.L.M. ter
Reek, J.M.P.A. van den
Jardin, Kristian Gaarn Du
Barbero-castillo, Almudena
Jong, E.M.G.J. de
Lubeek, S.F.K.
Haar, E.L.M. ter
Reek, J.M.P.A. van den
Jardin, Kristian Gaarn Du
Barbero-castillo, Almudena
Jong, E.M.G.J. de
Lubeek, S.F.K.
Source :: Acta Dermato-Venereologica, 103
Publication Year :: 2023
Abstract: Contains fulltext : 298930.pdf (Publisher’s version ) (Open Access)

Tools